Dexmedetomidine-Esketamine Combination on Depression and Anxiety After Laparoscopic Ureteral Reconstruction

Clinical trial NCT07753772 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07753772
Sponsor: Peking University First Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Ureteral Stricture Dexmedetomidine Esketamine Depressive Symptoms Anxiety

Start date: 2026-08-01
Primary completion: 2029-07-01
Enrollment: 658

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.